HK1155972A1 - 羥甲基丁酸鹽組合物及其用途 - Google Patents
羥甲基丁酸鹽組合物及其用途Info
- Publication number
- HK1155972A1 HK1155972A1 HK11110329.8A HK11110329A HK1155972A1 HK 1155972 A1 HK1155972 A1 HK 1155972A1 HK 11110329 A HK11110329 A HK 11110329A HK 1155972 A1 HK1155972 A1 HK 1155972A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- hydroxymethylbutyrate
- compositions
- hydroxymethylbutyrate compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/810,762 US20050215640A1 (en) | 2004-03-26 | 2004-03-26 | HMB compositions and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1155972A1 true HK1155972A1 (zh) | 2012-06-01 |
Family
ID=34990887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11110329.8A HK1155972A1 (zh) | 2004-03-26 | 2007-05-22 | 羥甲基丁酸鹽組合物及其用途 |
Country Status (15)
Country | Link |
---|---|
US (9) | US20050215640A1 (zh) |
EP (3) | EP1727534A2 (zh) |
JP (3) | JP5145033B2 (zh) |
KR (2) | KR20130010912A (zh) |
CN (1) | CN101212961A (zh) |
AU (1) | AU2005235133B2 (zh) |
BR (1) | BRPI0509017A (zh) |
CA (2) | CA2560042C (zh) |
EC (1) | ECSP066873A (zh) |
ES (2) | ES2699161T3 (zh) |
HK (1) | HK1155972A1 (zh) |
IL (1) | IL178039A0 (zh) |
MX (1) | MXPA06010922A (zh) |
TW (1) | TWI369981B (zh) |
WO (1) | WO2005102301A2 (zh) |
Families Citing this family (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050215640A1 (en) | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
PL371081A1 (pl) * | 2004-11-08 | 2006-05-15 | Sgp & Sons Ab | Preparat farmaceutyczny wpływający na procesy wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt oraz zastosowanie preparatu farmaceutycznego w procesie wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt |
ES2548432T3 (es) | 2005-12-19 | 2015-10-16 | Abbott Laboratories | Uso de beta-hidroxi-beta-metilbutirato para modular el desequilibrio en la producción de citoquinas de tipo 1 y tipo 2 |
US9358242B2 (en) | 2007-08-30 | 2016-06-07 | Prelief Inc. | Calcium glycerophosphate for treating and preventing respiratory diseases or conditions |
PL2381784T3 (pl) * | 2008-12-09 | 2019-01-31 | Metabolic Technologies, Inc. | Interwencyjny produkt odżywczy w celu poprawy funkcji i siły mięśni |
US9539224B2 (en) | 2008-12-09 | 2017-01-10 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
US9770424B2 (en) | 2008-12-09 | 2017-09-26 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
US11173167B2 (en) | 2008-12-09 | 2021-11-16 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
US9259430B2 (en) | 2008-12-09 | 2016-02-16 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
US9707241B2 (en) | 2008-12-09 | 2017-07-18 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
US8785160B2 (en) | 2009-02-24 | 2014-07-22 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
JP2012518635A (ja) | 2009-02-24 | 2012-08-16 | リター ファーマシューティカルズ インコーポレイテッド | プレバイオティック製剤および使用方法 |
US8298554B2 (en) | 2009-04-29 | 2012-10-30 | Amarin Pharmaceuticals Ireland Limited | Stable pharmaceutical composition and methods of using same |
CN104042617A (zh) | 2009-04-29 | 2014-09-17 | 阿马里纳药物爱尔兰有限公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
PT2443246T (pt) | 2009-06-15 | 2018-03-14 | Amarin Pharmaceuticals Ie Ltd | Composições e métodos para reduzir os triglicéridos sem aumentar os níveis de ldl-c num indivíduo em terapia de estatinas concomitante |
NZ599061A (en) | 2009-09-23 | 2014-05-30 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
CN101704736A (zh) * | 2009-10-30 | 2010-05-12 | 黄再新 | β-羟基-β-甲基丁酸生产过程中氯气逸出时的应急处理方法 |
US8490829B2 (en) | 2009-11-24 | 2013-07-23 | Pepsico, Inc. | Personalized beverage dispensing device |
US9754437B2 (en) * | 2009-11-24 | 2017-09-05 | Pepsico, Inc. | Automated beverage formulation |
US8335592B2 (en) | 2009-11-24 | 2012-12-18 | Pepsico, Inc. | Beverage dispensing device |
WO2011075741A1 (en) * | 2009-12-18 | 2011-06-23 | Metabolic Technologies, Inc. | Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb) |
ES2436890T3 (es) * | 2010-01-29 | 2014-01-07 | Abbott Laboratories | Líquidos nutricionales envasados asépticamente que comprenden HMB |
RU2012125877A (ru) * | 2010-01-29 | 2014-03-10 | Эбботт Лэборетриз | Питательные эмульсии, содержащие бета-гидрокси-бета-метилбутират кальция (гмб кальция) и растворимый белок |
TWI508670B (zh) * | 2010-01-29 | 2015-11-21 | Abbott Lab | 包含經噴霧乾燥之hmb的營養粉末 |
US9241508B2 (en) * | 2010-01-29 | 2016-01-26 | Abbott Laboratories | Nutritional emulsions comprising calcium HMB |
US9693577B2 (en) | 2010-01-29 | 2017-07-04 | Abbott Laboratories | Method of preparing a nutritional powder comprising spray dried HMB |
MX2012008783A (es) * | 2010-01-29 | 2012-08-17 | Abbott Lab | Liquidos nutricionales en envases plasticos que comprenden beta-hidroxi-beta-metilbutirato (hmb). |
TWI526161B (zh) | 2010-06-10 | 2016-03-21 | 亞培公司 | 包含鈣hmb及可溶性蛋白質之實質上透明營養液 |
EP2444083A1 (en) * | 2010-10-21 | 2012-04-25 | Nestec S.A. | Cysteine and food intake |
US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
NZ778131A (en) | 2010-11-29 | 2023-03-31 | Amarin Pharmaceuticals Ie Ltd | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
US20130337144A1 (en) * | 2010-12-22 | 2013-12-19 | Abbott Laboratories | Nutritional products comprising calcium hmb and conjugated linoleic acid |
US20130338228A1 (en) * | 2010-12-27 | 2013-12-19 | Abbott Laboratories | Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate |
WO2012109105A1 (en) * | 2011-02-07 | 2012-08-16 | Abbott Laboratories | Nutritional products comprising beta-hydroxy-beta-methylbutyrate |
US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
US8715648B2 (en) | 2011-02-16 | 2014-05-06 | Pivotal Therapeutics Inc. | Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics |
US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
EP2675298A1 (en) | 2011-02-17 | 2013-12-25 | Abbott Laboratories | Methods for improving brain development and cognitive function using beta-hydroxy-beta-methylbutyrate |
EP2691089A1 (en) * | 2011-03-31 | 2014-02-05 | Nestec S.A. | Nutritional compositions for increasing arginine levels and methods of using same |
US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
EP2744489A4 (en) * | 2011-08-15 | 2015-03-18 | Abbott Lab | PROCESS FOR PRODUCING HMB AND ITS SALTS |
US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
WO2013070735A1 (en) | 2011-11-07 | 2013-05-16 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
ES2891473T3 (es) | 2012-01-06 | 2022-01-28 | Amarin Pharmaceuticals Ie Ltd | Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto |
ES2421187B1 (es) * | 2012-02-23 | 2014-11-26 | Abbott Laboratories | Metodo para mejorar el desarrollo cerebral y la funcion cognitiva usando beta-hidroxi-beta-metilbutirato |
US20150119339A1 (en) * | 2012-06-11 | 2015-04-30 | Abbott Laboratories | Use of hmb to improve health outcomes for hospitalized patients |
NZ743706A (en) | 2012-06-29 | 2019-08-30 | Amarin Pharmaceuticals Ie Ltd | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy |
US20140037813A1 (en) * | 2012-08-02 | 2014-02-06 | Mead Johnson Nutrition Company | Nutritional creamer composition |
CN105025891B (zh) * | 2012-09-10 | 2020-01-21 | 代谢科技有限公司 | Hmb和atp的组合物及使用方法 |
CN104619198A (zh) * | 2012-09-17 | 2015-05-13 | 雅培制药有限公司 | 含有β-羟基-β-甲基丁酸的组合物及其用途 |
MX2015003660A (es) | 2012-09-21 | 2015-06-05 | Abbott Lab | Composiciones nutricionales que incluyen beta-hidroxi-beta-metilbu tirato de calcio, proteina y bajos niveles de electrolitos. |
US20150265566A1 (en) | 2012-11-06 | 2015-09-24 | Amarin Pharmaceuticals Ireland Limited | Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy |
US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
AU2014207707B2 (en) | 2013-01-15 | 2018-11-01 | Nusirt Sciences, Inc. | Treating pulmonary conditions |
US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
EP2996487B1 (en) | 2013-03-08 | 2019-12-11 | Axiom Foods Inc. | Rice protein supplements |
WO2014152606A2 (en) | 2013-03-14 | 2014-09-25 | Abbott Laboratories | Treatment of insulin resistance associated with prolonged physical inactivity |
US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
US20150057350A1 (en) * | 2013-08-23 | 2015-02-26 | Abbott Laboratories | Fibrosis biomarkers and methods of using same |
US20150065572A1 (en) | 2013-09-04 | 2015-03-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
JP6349575B2 (ja) * | 2013-12-03 | 2018-07-04 | 小林香料株式会社 | Hmbを含有する酸性飲料 |
WO2015094925A1 (en) | 2013-12-18 | 2015-06-25 | Capsugel Belgium Nv | Stable liquid filled hard capsule comprising beta-hydroxy-beta-methylbutyric acid |
WO2015094767A1 (en) * | 2013-12-18 | 2015-06-25 | Abbott Laboratories | Methods for maintaining or increasing bodyweight using decaffeinated green tea extract |
WO2015105981A2 (en) * | 2014-01-09 | 2015-07-16 | Abbott Laboratories | Conditional essentiality of hmb |
JP6480964B2 (ja) * | 2014-03-14 | 2019-03-13 | メタボリック・テクノロジーズ,インコーポレーテッド | 遊離酸形のβ−ヒドロキシ−β−メチル酪酸(HMB)を含有する液体及び食品ならびにその製造法 |
US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
WO2015195662A1 (en) | 2014-06-16 | 2015-12-23 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids |
US20160184248A1 (en) * | 2014-12-15 | 2016-06-30 | University Of Central Florida Research Foundation Inc. | Compositions and methods of use of -hydroxy-methylbutyrate (hmb) resulting in an acute endocrine response |
DK3302704T3 (da) * | 2015-06-01 | 2023-02-13 | Metabolic Tech Inc | Sammensætninger og fremgangsmåder til anvendelse af beta-hydroxy-beta-methylbutyrat (hmb) til reduktion af fedtmasse |
CN108697674B (zh) | 2015-09-16 | 2021-09-14 | 代谢科技有限公司 | 用于增强从软组织创伤恢复的β-羟基-β-甲基丁酸(HMB)的组合物和使用β-羟基-β-甲基丁酸(HMB)的方法 |
JP7401969B2 (ja) * | 2016-01-13 | 2023-12-20 | メタボリック・テクノロジーズ,インコーポレーテッド | 関節安定性のためのβ-ヒドロキシ-β-メチルブチレート(HMB)の組成物および使用方法 |
US11406609B2 (en) | 2016-01-21 | 2022-08-09 | Metabolic Technologies, Inc. | Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy |
CN109641135A (zh) | 2016-01-21 | 2019-04-16 | 代谢科技有限公司 | β-羟基-β-甲基丁酸(HMB)用于调节自噬和噬脂的组合物和方法 |
US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
BR112019021742A2 (pt) | 2017-04-17 | 2020-05-05 | Univ Chicago | composição, sistema, composição farmacêutica, composição alimentícia ou nutracêutica, método e uso da composição |
CN110868870A (zh) | 2017-05-12 | 2020-03-06 | 艾斯姆食品公司 | 大米产物及制备它们的系统和方法 |
WO2018213663A1 (en) | 2017-05-19 | 2018-11-22 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject having reduced kidney function |
CU20200012A7 (es) | 2017-08-14 | 2021-02-04 | Axcella Health Inc | Composiciones de aminoácidos para el tratamiento de enfermedad hepática |
US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
CN108558707A (zh) * | 2018-04-13 | 2018-09-21 | 太仓运通新材料科技有限公司 | 一种三肌酸hmb盐的制备方法 |
WO2019246225A1 (en) | 2018-06-20 | 2019-12-26 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
IL261670B (en) * | 2018-09-06 | 2019-06-30 | Tudu Holdings Ltd | Magnesium-containing formulation and uses thereof |
MX2021002553A (es) | 2018-09-24 | 2021-04-29 | Amarin Pharmaceuticals Ie Ltd | Metodos para reducir el riesgo de eventos cardiovasculares en un sujeto. |
US10888576B2 (en) | 2018-10-08 | 2021-01-12 | Metabolic Technologies, Inc. | Composition of HMB and ATP and methods of use |
JP7286964B2 (ja) * | 2018-12-28 | 2023-06-06 | 日油株式会社 | β-ヒドロキシ-β-メチル酪酸、タンパク質、及び液状油脂を含有する液状栄養組成物 |
CN111714616A (zh) * | 2019-07-17 | 2020-09-29 | 江苏西宏生物医药有限公司 | 一种用于抗肿瘤的组合物 |
JP2021069308A (ja) * | 2019-10-30 | 2021-05-06 | 小林製薬株式会社 | 経口組成物 |
WO2021183740A1 (en) * | 2020-03-12 | 2021-09-16 | Abbott Laboratories | Methods of treating diarrhea or inflammatory conditions of the gut |
JP2023530485A (ja) * | 2020-06-17 | 2023-07-18 | メタボリック・テクノロジーズ,エルエルシー | 運動なしで、筋量、筋力および筋機能を改善するためのβ-ヒドロキシ-β-メチルブチレート(HMB)の組成物および使用法 |
WO2022090458A1 (en) * | 2020-10-30 | 2022-05-05 | Société des Produits Nestlé S.A. | Compositions containing nicotinamide and vitamin b6 and methods of using such compositions for treating sarcopenia and frailty |
MX2023004559A (es) * | 2020-10-30 | 2023-05-04 | Nestle Sa | Composiciones que contienen nicotinamida y vitamina b6 y metodos de uso de tales composiciones para promover el crecimiento muscular. |
WO2022090457A1 (en) * | 2020-10-30 | 2022-05-05 | Société des Produits Nestlé S.A. | Compositions containing nicotinamide and vitamin b6 and methods of using such compositions for treating cachexia or precachexia |
JP2023547068A (ja) * | 2020-10-30 | 2023-11-09 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | ニコチンアミド及びビタミンb6を含有する組成物、並びにリハビリテーションのためにかかる組成物を使用する方法 |
WO2023031226A1 (en) * | 2021-08-31 | 2023-03-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of branched chain fatty acids (bcfas) for the treatment of intestinal inflammation |
Family Cites Families (128)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US597650A (en) | 1898-01-18 | morris | ||
US3408210A (en) * | 1965-06-14 | 1968-10-29 | Wilbert A. Heyman | Dehydration of foods |
US3542560A (en) * | 1967-12-06 | 1970-11-24 | American Home Prod | Infant formula with fat composition like human milk |
GB1446965A (en) * | 1974-02-14 | 1976-08-18 | Agricultural Vegetable Prod | Preparation of food products |
US4104290A (en) * | 1975-02-07 | 1978-08-01 | H.L.S. Ltd., Industrial Engineering Company | Process for separating oils and fats into liquid and solid fractions |
US4311645A (en) | 1980-03-24 | 1982-01-19 | Hoffmann-La Roche Inc. | Synthesis of SRS-active compounds |
US4871768A (en) | 1984-07-12 | 1989-10-03 | New England Deaconess Hospital Corporation | Dietary supplement utilizing ω-3/medium chain trigylceride mixtures |
US4866040A (en) * | 1986-01-06 | 1989-09-12 | Alfred Stracher | Aminocarnitine directed pharmaceutical agents |
US4742081A (en) * | 1986-01-06 | 1988-05-03 | Alfred Stracher | Carnitine coupled pharmaceutical agents |
DE3620433A1 (de) | 1986-06-18 | 1987-12-23 | Boehringer Ingelheim Kg | Verwendung von 2-(n-2,6-dichlorphenyl-n-allyl-amino)-imidazolin-(2) als cytoprotektives mittel |
ES2052066T3 (es) | 1988-10-31 | 1994-07-01 | Sandoz Nutrition Ltd | Mejoras en o relacionadas con compuestos organicos. |
US5000975A (en) * | 1988-12-29 | 1991-03-19 | American Home Products Corporation | Randomized palm oil fat composition for infant formulas |
CA2010511A1 (en) | 1989-03-01 | 1990-09-01 | Roberto L. Ceriani | Method of enhancing cancer therapy by administration of unsaturated fatty acids |
GB8906369D0 (en) * | 1989-03-20 | 1989-05-04 | Tisdale Michael J | Eicosapentaenoic acid |
US5457130A (en) * | 1989-03-20 | 1995-10-10 | Cancer Research Campaign Technology Limited | Eicosapentaenoic acid used to treat cachexia |
US5157022A (en) | 1989-11-22 | 1992-10-20 | Adrian Barbul | Method for reducing blood cholesterol using arginine |
US5087472A (en) * | 1990-01-30 | 1992-02-11 | Iowa State University Research Foundation, Inc. | Feed compositions for domestics animals containing hydroxymethylbutyrate |
US5028440A (en) * | 1990-01-30 | 1991-07-02 | Iowa State University Research Foundation, Inc. | Method of raising meat producing animals to increase lean tissue development |
US4992470A (en) * | 1990-02-08 | 1991-02-12 | Iowa State University Research Foundation, Inc. | Method of enhancing immune response of mammals |
US5167957A (en) * | 1990-09-06 | 1992-12-01 | Virginia Tech Intellectual Properties, Inc. | Compositions and methods for the treatment of dietary deficiencies |
US5601860A (en) * | 1990-11-30 | 1997-02-11 | American Home Products Corporation | Corandomized fat compositions for infant formulas |
KR100219771B1 (ko) | 1991-03-18 | 1999-10-01 | 이치로 키타사토 | 돼지용 사료 및 이를 사용하는 돼지 사육법 |
US5085883A (en) | 1991-06-27 | 1992-02-04 | Abbott Laboratories | Blend of dietary fiber for nutritional products |
US5171442A (en) * | 1991-10-18 | 1992-12-15 | Nakshbendi Ghassan F | Water purification apparatus |
US5223285A (en) * | 1992-03-31 | 1993-06-29 | Abbott Laboratories | Nutritional product for pulmonary patients |
CA2142314C (en) * | 1992-09-16 | 1999-06-01 | Steven L. Nissen | Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol |
US5447732A (en) | 1992-11-25 | 1995-09-05 | Ajinomoto Co., Inc. | High-absorption mineral-containing composition and foods |
US5348979A (en) | 1992-12-23 | 1994-09-20 | Iowa State University Research Foundation Inc. | Method of promoting nitrogen retention in humans |
ATE157117T1 (de) | 1993-05-13 | 1997-09-15 | Loders Croklaan Bv | Muttermilch-ersatzstoffe aus umgeestertentriglyceridmischungen |
US6136858A (en) * | 1994-01-10 | 2000-10-24 | Abbott Laboratories | Infant formula and methods of improving infant stool patterns |
US5952314A (en) * | 1994-04-01 | 1999-09-14 | Demichele; Stephen Joseph | Nutritional product for a person having ulcerative colitis |
US5780451A (en) * | 1994-04-01 | 1998-07-14 | Abbott Laboratories | Nutritional product for a person having ulcerative colitis |
US5444054A (en) * | 1994-04-01 | 1995-08-22 | Abbott Labatories | Method of treating ulcerative colitis |
US5576287A (en) * | 1994-04-29 | 1996-11-19 | Wake Forest University | Method for treating acute renal disease and failure |
US5726146A (en) * | 1994-12-06 | 1998-03-10 | Natural Supplement Association, Incorporated | Non-steroidal, anabolic dietary supplement and method to increase lean mass without linked increase fat mass |
KR0140248B1 (ko) | 1995-03-23 | 1998-06-15 | 한상기 | 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법 |
DE19528461A1 (de) | 1995-08-03 | 1997-02-06 | Braun Melsungen Ag | Präparat zur Ernährung |
US5641531A (en) | 1995-09-28 | 1997-06-24 | Abbott Laboratories | Nutritional liquid supplement beverage and method of making same |
CN1086282C (zh) | 1995-12-15 | 2002-06-19 | 普罗克特和甘保尔公司 | 含有多磷酸盐防腐剂体系和少量黄原胶的,具有稳定的风味乳浊液/混浊乳浊液的饮料 |
DE69736679T2 (de) * | 1996-04-11 | 2006-12-28 | Loders Croklaan B.V. | Fliessfähige fettzusammensetzung |
US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
US5756469A (en) | 1996-07-26 | 1998-05-26 | Beale; Paxton K. | Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal |
US7504376B2 (en) * | 1996-08-12 | 2009-03-17 | Natural Alternatives International | Methods and compositions for increasing the anaerobic working capacity in tissues |
US6080788A (en) * | 1997-03-27 | 2000-06-27 | Sole; Michael J. | Composition for improvement of cellular nutrition and mitochondrial energetics |
DE29707308U1 (de) | 1997-04-23 | 1997-06-26 | Kunz Armin | Präparat zur Muskelerhaltung bzw. zur Förderung des Muskelaufbaus |
US6660258B1 (en) * | 1997-05-09 | 2003-12-09 | Pharma Pacific Pty Ltd | Oromucosal cytokine compositions and uses thereof |
US6103764A (en) * | 1997-11-07 | 2000-08-15 | Iowa State University Research Foundation, Inc. | Method for increasing the aerobic capacity of muscle |
US6013665A (en) | 1997-12-16 | 2000-01-11 | Abbott Laboratories | Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
US6194379B1 (en) | 1998-05-01 | 2001-02-27 | Abbott Laboratories | Elemental enteral formula |
US6475539B1 (en) | 1998-05-07 | 2002-11-05 | Abbott Laboratories | Nutritionally complete low pH enteral formula |
JP4175698B2 (ja) * | 1998-06-19 | 2008-11-05 | サントリー株式会社 | 新規なトリグリセリド及びそれを含む組成物 |
US6031000A (en) * | 1998-06-23 | 2000-02-29 | Iowa State University Research Foundation, Inc. | Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use |
WO2000006134A2 (en) * | 1998-07-30 | 2000-02-10 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity |
US5976550A (en) * | 1998-11-20 | 1999-11-02 | Engel; Peter H. | Dietary food supplement |
US20010008641A1 (en) * | 1998-11-25 | 2001-07-19 | R. Douglas Krotzer | Nutritionally active composition for bodybuilding |
JP3973786B2 (ja) | 1998-12-28 | 2007-09-12 | 松下電器産業株式会社 | スパッタリング方法及び装置 |
US6294206B1 (en) * | 1999-04-09 | 2001-09-25 | Abbott Laboratories | Powdered human milk fortifier |
US6291525B1 (en) * | 1999-09-08 | 2001-09-18 | Iowa State University Research Foundation, Inc. | Method for improving a human's perception of his emotional state |
DE60032781D1 (de) * | 1999-10-18 | 2007-02-15 | Muscletech Res And Dev Inc | Nahrungsmittelzusatz zur zunahme der fettarmen körpermasse und kraft |
GB9929919D0 (en) | 1999-12-17 | 2000-02-09 | Hannah Research Inst The | Calcium phosphate nanoclusters and their applications |
US6521591B1 (en) * | 2000-02-10 | 2003-02-18 | N.V. Nutricia | Pharmaceutical composition for muscular anabolism |
US7250397B2 (en) * | 2000-02-23 | 2007-07-31 | Zealand Pharma A/S | Antiarrhythmic peptides |
JP2004506746A (ja) | 2000-04-06 | 2004-03-04 | コンリンコ, インコーポレイテッド | 共役リノール酸組成物 |
JP4625156B2 (ja) * | 2000-04-10 | 2011-02-02 | イーエヌ大塚製薬株式会社 | 癌化学療法に伴う副作用軽減剤 |
US6420342B1 (en) * | 2000-05-08 | 2002-07-16 | N.V. Nutricia | Nutritional preparation comprising ribose and medical use thereof |
US20050106219A1 (en) * | 2000-05-30 | 2005-05-19 | Karlheinz Bortlik | Primary composition comprising a lipophilic bioactive compound |
CN100475266C (zh) | 2000-08-03 | 2009-04-08 | 北卡罗来纳州大学 | 经卵内喂养增强卵生物种的发育 |
ATE295690T1 (de) | 2000-08-29 | 2005-06-15 | Lonza Ag | Verfahren zur herstellung einer granulierbaren mischung und carnitin-magnesium-hydroxycitrat |
US20030203070A1 (en) * | 2000-09-26 | 2003-10-30 | The Procter & Gamble Company | Compositions containing sorbitan monoesters |
EP1198991B1 (en) * | 2000-10-20 | 2012-12-19 | Nutriz N.V: | Non-dairy products derived from rice |
NZ521894A (en) * | 2001-02-15 | 2006-08-31 | Adeka Corp | Products containing beta-glucan |
JP3735070B2 (ja) * | 2001-03-26 | 2006-01-11 | 花王株式会社 | 容器詰乳化飲料 |
US6620427B2 (en) * | 2001-04-24 | 2003-09-16 | Abbott Laboratories | Method for improving bone mineralization |
US20030021877A1 (en) * | 2001-06-13 | 2003-01-30 | Cain Frederick William | Micronised fat particles |
DE10145818C1 (de) | 2001-09-17 | 2002-10-10 | Alfill Engineering Gmbh & Co K | Sterilisiervorrichtung mit H202-Verdampfer |
GB2381451A (en) * | 2001-11-01 | 2003-05-07 | New Technology Res Ltd | Pharmaco-dietary preparation having nutrition-supplementing and nutrition-enhancing effect |
JP2003137790A (ja) * | 2001-11-01 | 2003-05-14 | Mie Kariyou Kk | β−2,1(β2→β1)結合連鎖フラクトースオリゴマーを含有するフラクトオリゴ糖を有効成分とする医薬 |
ATE522264T1 (de) * | 2001-12-12 | 2011-09-15 | Martek Biosciences Corp | Extrahieren und entstearinieren von lipiden aus biomasse |
US7168581B2 (en) * | 2001-12-21 | 2007-01-30 | Rexam Medical Packaging Inc. | Closure for a retort processed container having a peelable seal |
DE10163676A1 (de) | 2001-12-21 | 2003-07-10 | Phenion Gmbh & Co Kg | Verwendung von Hyperforin oder Extrakten aus Johanniskraut gegen anaphylaktische Schockzustände oder Osteoporose |
US20030165579A1 (en) | 2002-02-27 | 2003-09-04 | Chih-Hui Lin | Euphorbia antiquorum extract, a pharmaceutical composition containing the same and methods for treatment of cancers |
WO2003091214A1 (en) | 2002-04-23 | 2003-11-06 | Aventis Pharmaceuticals Inc. | 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo |
SE0201581D0 (sv) * | 2002-05-29 | 2002-05-29 | Scandinavian Biotechnology Res | New improved acyltransferase |
US20040013787A1 (en) * | 2002-06-28 | 2004-01-22 | Theuer Richard C. | Fat compositions for infant formula and methods therefor |
US20040048925A1 (en) * | 2002-09-09 | 2004-03-11 | Wiley David B. | Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives |
US20040106678A1 (en) * | 2002-09-17 | 2004-06-03 | Dobbins Thomas A | Compositions for the parenteral administration of calcium and magnesium |
WO2004035624A2 (en) * | 2002-10-14 | 2004-04-29 | Novo Nordisk A/S | Glucagon - like peptide - 2 variants |
US7445807B2 (en) * | 2002-10-15 | 2008-11-04 | Western Holdings, Llc | Agglomerated granular protein-rich nutritional supplement |
GB0301554D0 (en) | 2003-01-23 | 2003-02-26 | Molecularnature Ltd | Immunostimulatory compositions |
US7332178B2 (en) * | 2003-04-25 | 2008-02-19 | Abbott Laboratories | Stable nutritional powder containing ascorbyl palmitate |
FR2856596B1 (fr) | 2003-06-27 | 2007-04-27 | Bioprojet Soc Civ | Nouvelle association medicamenteuse psychiatrique et utilisation d'une antagoniste ou agoniste inverse du recepteur h3 de l'histamine pour preparer un medicament prevenant des effets indesirables de psychotropes. |
CA2542612A1 (en) * | 2003-10-14 | 2005-04-21 | Kingston Henry Gordon Mills | Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease |
IL158555A0 (en) * | 2003-10-22 | 2004-05-12 | Enzymotec Ltd | Human breast milk lipid mimetic as dietary supplement |
ES2314485T3 (es) * | 2003-12-24 | 2009-03-16 | N.V. Nutricia | Composiciones que comprenden acido pantotenico o derivados del mismo y su uso para estimular el apetito. |
US7696241B2 (en) | 2004-03-04 | 2010-04-13 | Bristol-Myers Squibb Company | Bicyclic compounds as modulators of androgen receptor function and method |
US20050215640A1 (en) | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
US20050249650A1 (en) * | 2004-05-07 | 2005-11-10 | Fmc Technologies, Inc. | Immersion retort |
ATE492170T1 (de) * | 2004-09-09 | 2011-01-15 | Nestec Sa | Herstellungsmethoden für nahrungsmittel mit verbesserter qualität |
WO2006031699A2 (en) * | 2004-09-10 | 2006-03-23 | Diversa Corporation | Compositions and methods for making and modifying oils |
PL371081A1 (pl) | 2004-11-08 | 2006-05-15 | Sgp & Sons Ab | Preparat farmaceutyczny wpływający na procesy wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt oraz zastosowanie preparatu farmaceutycznego w procesie wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt |
US8067052B2 (en) * | 2005-02-25 | 2011-11-29 | Siddharth Shastri | Nutritional composition and a container for the convenient transport and storage of the nutritional composition |
CA2537452C (en) * | 2005-03-09 | 2013-12-24 | Abbott Laboratories | Concentrated human milk fortifier liquid |
EP1876913A1 (en) * | 2005-04-27 | 2008-01-16 | Enzymotec Ltd. | Human milk fat substitutes |
CA2606300A1 (en) * | 2005-06-06 | 2006-12-14 | Bristol-Myers Squibb Company | Low-phytate infant formulas |
BRPI0615396A2 (pt) | 2005-08-26 | 2011-05-17 | Nestec Sa | composição nutricional para a prevenção ou tratamento de má-nutrição em um paciente obeso, bem como uso de uma fonte de proteìna, vitamina a, vitamina c, vitamina e, zinco e selênio para sua preparação |
MY147363A (en) * | 2005-09-20 | 2012-11-30 | Nestec Sa | Water dispersible composition and method for preparing same |
US20090182050A1 (en) | 2005-10-07 | 2009-07-16 | Ocean Nutrition Canada, Ltd. | Salts of Fatty Acids and Methods of Making and Using thereof |
EP1973426A2 (en) * | 2005-11-03 | 2008-10-01 | Southwest Immunology Inc. | Compositions for preventing and reducing delayed onset muscle soreness |
ES2548432T3 (es) | 2005-12-19 | 2015-10-16 | Abbott Laboratories | Uso de beta-hidroxi-beta-metilbutirato para modular el desequilibrio en la producción de citoquinas de tipo 1 y tipo 2 |
CA2637852A1 (en) * | 2006-01-31 | 2007-08-09 | Nestec S.A. | Nutritional composition for low birth weight infants |
US20080119552A1 (en) * | 2006-11-17 | 2008-05-22 | Novus International Inc. | Matrix-embedded compositions having organic acids and fatty acids |
US20080194407A1 (en) | 2007-02-14 | 2008-08-14 | Ashmead H Dewayne | High nitrogen containing chelate compositions suitable for plant delivery |
US20090110674A1 (en) | 2007-10-24 | 2009-04-30 | Loizou Nicos C | Health supplement |
US8029830B2 (en) * | 2008-04-18 | 2011-10-04 | Nuvocare Health Services Inc. | Composition and method for promoting internal health and external appearance |
CA2723441A1 (en) | 2008-05-21 | 2009-11-26 | Stokely-Van Camp, Inc. | Milk-based recovery beverage |
PL2381784T3 (pl) * | 2008-12-09 | 2019-01-31 | Metabolic Technologies, Inc. | Interwencyjny produkt odżywczy w celu poprawy funkcji i siły mięśni |
JP2009155336A (ja) | 2009-03-31 | 2009-07-16 | Tsujido Chemical Corp | 治療剤 |
US20090312419A1 (en) | 2009-08-12 | 2009-12-17 | Kneller Bruce W | CREATINE -ßALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE |
PL217815B1 (pl) | 2009-12-14 | 2014-08-29 | Olimp Lab Spółka Z Ograniczoną Odpowiedzialnością | Napój izotoniczny z chelatami |
CN101785566A (zh) | 2010-01-22 | 2010-07-28 | 北京康比特体育科技股份有限公司 | 一种含有hmb的运动饮料 |
US9241508B2 (en) | 2010-01-29 | 2016-01-26 | Abbott Laboratories | Nutritional emulsions comprising calcium HMB |
TWI526161B (zh) | 2010-06-10 | 2016-03-21 | 亞培公司 | 包含鈣hmb及可溶性蛋白質之實質上透明營養液 |
US10869843B2 (en) | 2010-11-23 | 2020-12-22 | Chemi Nutra | Method for increasing muscle mass and strength |
US20130338228A1 (en) | 2010-12-27 | 2013-12-19 | Abbott Laboratories | Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate |
WO2012097061A1 (en) | 2011-01-13 | 2012-07-19 | Abbott Laboratories | Nutritional compositions and methods for improving skeletal muscle protein metabolism |
WO2013056048A2 (en) | 2011-10-13 | 2013-04-18 | Abbott Laboratories | Nutritional products comprising beta-alanine |
WO2013170189A1 (en) | 2012-05-11 | 2013-11-14 | Abbott Laboratories | Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow |
US20150119339A1 (en) | 2012-06-11 | 2015-04-30 | Abbott Laboratories | Use of hmb to improve health outcomes for hospitalized patients |
-
2004
- 2004-03-26 US US10/810,762 patent/US20050215640A1/en not_active Abandoned
- 2004-12-29 US US11/025,466 patent/US8217077B2/en active Active
-
2005
- 2005-03-14 KR KR1020127033546A patent/KR20130010912A/ko not_active Application Discontinuation
- 2005-03-14 WO PCT/US2005/007951 patent/WO2005102301A2/en active Application Filing
- 2005-03-14 MX MXPA06010922A patent/MXPA06010922A/es active IP Right Grant
- 2005-03-14 JP JP2007504991A patent/JP5145033B2/ja active Active
- 2005-03-14 ES ES11187274T patent/ES2699161T3/es active Active
- 2005-03-14 EP EP05732120A patent/EP1727534A2/en not_active Withdrawn
- 2005-03-14 CA CA2560042A patent/CA2560042C/en not_active Expired - Fee Related
- 2005-03-14 ES ES10186645.7T patent/ES2586402T3/es active Active
- 2005-03-14 AU AU2005235133A patent/AU2005235133B2/en not_active Ceased
- 2005-03-14 EP EP10186645.7A patent/EP2301529B1/en not_active Not-in-force
- 2005-03-14 CN CNA2005800095960A patent/CN101212961A/zh active Pending
- 2005-03-14 KR KR1020067022383A patent/KR101253063B1/ko not_active IP Right Cessation
- 2005-03-14 CA CA2807787A patent/CA2807787C/en active Active
- 2005-03-14 EP EP11187274.3A patent/EP2444082B1/en not_active Not-in-force
- 2005-03-14 BR BRPI0509017-2A patent/BRPI0509017A/pt active Search and Examination
- 2005-03-25 TW TW094109357A patent/TWI369981B/zh active
-
2006
- 2006-09-12 IL IL178039A patent/IL178039A0/en unknown
- 2006-09-22 EC EC2006006873A patent/ECSP066873A/es unknown
-
2007
- 2007-05-22 HK HK11110329.8A patent/HK1155972A1/zh not_active IP Right Cessation
-
2012
- 2012-01-11 US US13/348,026 patent/US8609725B2/en not_active Expired - Fee Related
- 2012-01-11 US US13/347,956 patent/US8785495B2/en not_active Expired - Lifetime
- 2012-01-11 US US13/347,877 patent/US8778993B2/en not_active Expired - Fee Related
- 2012-01-11 US US13/348,035 patent/US8778994B2/en not_active Expired - Lifetime
- 2012-01-11 US US13/347,978 patent/US20120189715A1/en not_active Abandoned
- 2012-01-11 US US13/347,985 patent/US20120177752A1/en not_active Abandoned
- 2012-01-11 US US13/348,024 patent/US8785496B2/en not_active Expired - Lifetime
- 2012-06-21 JP JP2012139422A patent/JP5732437B2/ja active Active
-
2015
- 2015-03-09 JP JP2015045519A patent/JP2015147773A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1155972A1 (zh) | 羥甲基丁酸鹽組合物及其用途 | |
EP1895838A4 (en) | COMPOSITIONS AND METHODS | |
EP1718714A4 (en) | COMPOSITIONS CONTAINING A PLOTTER | |
EP1799213A4 (en) | NEW CURCUMINANALOGES AND USES THEREOF | |
ZA200704295B (en) | Arthrospira-based compositions and uses thereof | |
PT1883665T (pt) | Composições polilactídeo e usos das mesmas | |
ZA200904425B (en) | Nemathical compositions | |
EP1807071A4 (en) | ANTIPYRETIC METHODS AND COMPOSITIONS | |
EP1767612A4 (en) | SOLID FUEL COMPOSITION AND SOLID SOAP | |
GB0405406D0 (en) | Anti-vaginitis compositions | |
EP1848438A4 (en) | DIAMINOPHENOTHIAZINE COMPOSITIONS AND THEIR USE | |
EP1729574A4 (en) | PESTICIDE COMPOSITIONS | |
EP1991059A4 (en) | INSECTICIDAL COMPOSITIONS AND USES THEREOF | |
HK1101136A1 (en) | Compositions against sars-coronavirus and uses thereof | |
HK1098635A1 (en) | Pesticide compositions | |
GB0513431D0 (en) | Prophylactic compositions and uses | |
GB0420356D0 (en) | Detergent compositions and their manufacture | |
ZA200701197B (en) | Compositions | |
GB0501348D0 (en) | Compositions and methods | |
GB0410140D0 (en) | Compositions | |
GB0424051D0 (en) | Compounds and compositions | |
GB0325942D0 (en) | Compositions and uses thereof | |
GB0420627D0 (en) | Monoglyceride-containing compositions | |
GB0423292D0 (en) | Compounds and compositions | |
GB0428034D0 (en) | Compositions and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210314 |